Rheumatoid Arthritis Therapy Hinges on Infection Check
Screening for latent tuberculosis (TB), hepatitis C virus (HCV), and occult hepatitis B virus (HBV) is critical before initiating biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in patients with rheumatoid arthritis (RA), according to a recent clinical audit conducted in Pakistan.